Investingation on Outcomes After Combining Septoplasty With Additional Procedures.
NCT ID: NCT07127848
Last Updated: 2025-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
90 participants
INTERVENTIONAL
2025-04-01
2025-09-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This is a single-center prospective randomized interventional comparative study on patients in a tertiary rhinology center, who will undergo septoplasty alongside one additional rhinologic procedure aimed at improving nasal patency.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact Of Closure Of Patent Foramen Ovale On Apnoea-Hypopnoea-Index, Nocturnal Hypoxemia And Systemic Vascular Function In Patients With Obstructive Sleep Apnoea
NCT01780207
LATERAL PHARYNGOPLASTY OUTCOMES IN THE TREATMENT OF SNORE AND OBSTRUCTIVE SLEEP APNEA
NCT01574768
Nasal Obstruction in Sleep Apnea Patients Compared to the General Population
NCT01282125
Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction
NCT05582070
Determination of the Frequency and Predictors of Difficult Intubation in Septoplasty Operations
NCT06884592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The patients will be divided into three groups: those undergoing septoplasty with turbinectomy, those undergoing septoplasty with flaring sutures of the internal nasal valve and those undergoing septoplasty with radiofrequent ablation of the inferior nasal turbinates. Randomization will be performed via a binary coin-toss method, with allocation con-cealment, and using a heads-tails method on a true random number generator online service (TRNG).
Patients with a history of psychological or mental illness, prior nasal surgery or nasal polyposis will be excluded from the study. Use of any medication related to airway management or nasal patency, such as decongestants or mucolytics, or nasal dilators to influence the external and internal nasal valve function during the study period was not allowed.
Written informed consent will be obtained from all of the eligible patients. Primary outcome measures include subjective NOSE (Nasal Obstruction Symptom Evaluation) questionnaire scores - internationally validated scale for assessment of intensity of nasal obstruction, consisting of 5 claims related to nasal obstruction divided into Likert scales of 4 points for each claim (normal values 2.75-7, with scores \>7 indicating clinically relevant nasal obstruction), and objective peak nasal inspiratory flow measurements using a calibrated instrument (PNIF, GM Instruments, with normal values ranging from 130-140 l/min for healthy young adults), while anthropometric and demographic variables will be covariates\[12\].
PNIF is a noninvasive, easy to perform method commonly used to assess nasal patency. It is a physiologic measure indicating the peak nasal airflow in liters per minute achieved during maximal forced nasal inspiration \[ \]. To reduce test-retest variability and sampling bias due to the influence of the elasticity of the lateral nasal wall (the valve effect), three PNIF measurements will be performed preoperatively and repeated at onset and three months postoperatively, with the best measurement recorded for data analysis.
The study was designed to comply with CONSORT guidelines. A minimal study sample of 90 was calculated based on 80% study power and alpha error rate of 5% (G\*Power t-test).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Septoplasty with Mucotomy
Septoplasty accompanied by radiofrequent mucotomy of the inferior nasal turbinates.
Septoplasty with Valvuloplasty
Subtotal reconstruction of the nasal septum accompanied by surgical intervention by placing a flare sutture in the internal nasal valve area.
Septoplasty and Turbinectomy
Septoplasty accompanied by surgical resection of the inferior nasal turbinates.
Septoplasty with Mucotomy
Subtotal reconstruction of the nasal septum accompanied by radiofrequent nasal mucosal reduction of the inferior turbinates.
Septoplasty and Valvuloplasty
Septoplasty accompanied by placing a flaring sutture in the internal nasal valve area.
Septoplasty with Turbinectomy
Subtotal reconstruction of the nasal septum accompanied by surgical resection of the inferior turbinates.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Septoplasty with Mucotomy
Subtotal reconstruction of the nasal septum accompanied by radiofrequent nasal mucosal reduction of the inferior turbinates.
Septoplasty with Turbinectomy
Subtotal reconstruction of the nasal septum accompanied by surgical resection of the inferior turbinates.
Septoplasty with Valvuloplasty
Subtotal reconstruction of the nasal septum accompanied by surgical intervention by placing a flare sutture in the internal nasal valve area.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Sestre Milosrdnice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andro Košec, MD, PhD
Consultant Otorhinolaryngologist and Head and Neck Surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andro Košec, MD, PhD, FEBORL-HNS, FACS
Role: STUDY_CHAIR
University Hospital Center Sestre milosrdnice, Department of ORL&HNS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Center Sestre milosrdnice
Zagreb, , Croatia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hernandez AK, Uhl C, Haehner A, Cuevas M, Hummel T. Objective nasal airflow measures in relation to subjective nasal obstruction, trigeminal function, and olfaction in patients with chronic rhinosinusitis. Rhinology. 2024 Aug 1;62(4):394-402. doi: 10.4193/Rhin23.270.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.